New Medicines Reviews 2013
Reports on the role of SMC & Review of IPTR & ADTC
References
1. The Scottish Government. February 2012. CMO(2012)1: Guidance to Further Strengthen the Safe and Effective use of New Medicines Across the NHS in Scotland. [cited 2012 August 09]; Available from: http://www.sehd.scot.nhs.uk/cmo/CMO(2012)01.pdf
2. The Scottish Government. February 2012. CEL 17 (2010): Introduction and Availability of Newly Licensed Medicines in the NHS in Scotland. [cited 2012 August 09]; Available from: http://www.sehd.scot.nhs.uk/mels/CEL2010_17.pdf
3. The Scottish Government. March 2011. SGHD/CMO(2011)3: Implementing CEL 17 (2010): Introduction and Availability of Newly Licensed Medicines in the NHS in Scotland - Good Practice Guidance for NHS Board Management of Individual Patient Treatment Requests (IPTRs). [cited 2012 August 09]; Available from: http://www.sehd.scot.nhs.uk/cmo/CMO(2011)03.pdf
Contact
Email: VERONICA MOFFAT
There is a problem
Thanks for your feedback